83 Days
Source:
The Guardian
Starmer’s gift to Britain: US drug deal risks
The article criticizes UK Prime Minister Keir Starmer and government ministers for secretly approving a deal with the US that increases NHS drug spending and benefits pharmaceutical shareholders. The deal, struck with former US President Trump, bypassed parliamentary scrutiny and is projected to cost the NHS billions, potentially leading to hundreds of thousands of additional deaths due to reduced healthcare funding. The author condemns the lack of transparency and democratic oversight surrounding this agreement.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)